Zantac Lawsuit

Active Case

Heartburn can be frustrating to manage and can also be incredibly painful. Trying to live without heartburn by taking medication should not also come with worries that a medication may potentially cause cancer.

January 10, 2020

Case Update:  DRUG MANUFACTURERS ANNOUNCE RECALL OF POPULAR ANTACIDS OVER CANCER CONCERNS

Certain batches of generic heartburn medicine ranitidine (known as Zantac under the brand name drug version) tablets and capsules contain N-Nitrosodimethylamine (NDMA), a substance that the World Health Organization determined may cause cancer in humans, the FDA announced. The recalls are the latest in a series affecting name brand and generic versions of the popular antacid. Drug manufacturers Appco Pharma and Northwind Pharmaceuticals announced recalls of ranitidine products in January 2020. Mylan also recalledbatches of a similar prescribed antacid nizatidine due to the potentially toxic substance.

Appco Pharma’s recall includes certain batches that will expire in April or May of 2021, while Northwind Pharmaceuticals’ contains certain 150mg and 300 mg tablets. Read more.

Zantac® is a type of medication with histamine-2 blockers that help decrease the amount of acid created by the stomach. On Oct. 18, 2019, manufacturer Sanofi announced a voluntary recall of its over-the-counter brand-name heartburn drug Zantac due to it containing N-Nitrosodimethylamine (NDMA), which may cause cancer in humans.

Contact an attorney

If you or a loved one have been diagnosed with stomach, bladder, kidney, pancreatic or colon cancer after taking Zantac to treat heartburn, you may contact Motley Rice medical attorney Carmen Scott and Daniel Lapinski by email or call 1.800.768.4026 for more information or to discuss your potential claim.

Zantac voluntary recall

Sold both over-the-counter and as a prescription, Zantac is one of H2 (histamine-2) blockers used to decrease the amount of acid in the stomach. Over-the-counter versions are used to treat common conditions such as heartburn and indigestion. Prescription options of the product are also available to treat and prevent more severe conditions, such as ulcers and gastroesophageal reflux disease.

The Zantac recall includes:

  • Zantac 150®
  • Zantac 150® Cool Mint
  • Zantac 75®

Several U.S. retailers removed Zantac from their shelves in the days and weeks leading up to the recall, including Walmart, CVS, Walgreens and Rite Aid.

Zantac cancer lawsuit investigation

Motley Rice is currently investigating reports of stomach, bladder, kidney, pancreatic and colon cancer related to Zantac heartburn medications. NDMA is an organic compound that may also be found in water and certain foods, including meats, dairy products, and vegetables, according to the FDA. Laboratory tests indicate that NDMA can cause cancer in humans. The FDA began investigating it and similar toxins in blood pressure and heart failure medications in 2018 and says that it has found “unacceptable levels” of NDMA in some ranitidine products.

Zantac lawsuit settlements

Zantac manufacturer Sanofi is currently facing allegations that it failed in its duty to protect consumers by producing a product that endangered their lives under the guise of treating their medical conditions. These investigations are still in the early stages and no verdicts or settlements have been reached as the result of litigation.

Our medical drug litigation experience

Motley Rice medical attorneys have extensive experience litigating for patients who have suffered severe adverse effects and complications caused by dangerous prescription and over-the-counter drugs. In addition to Zantac, we are also reviewing claims of chronic kidney disease and failure caused by proton pump inhibitors (PPI), used to treat GERD, frequent heartburn, ulcers, esophagitis and other conditions related to the over-production of stomach acid.

We understand that as a patient or family member, your familiarity with medications you have been prescribed, and knowledge of their potential risks, may be limited. Our attorneys have the resources needed to thoroughly investigate and identify potentially harmful products, medical causation, compliance with FDA regulations, alleged inadequacy of warnings, alleged wrongdoing and other factors that could affect your potential claim. 

In addition to stomach acid medications, our attorneys have represented clients in multiple medical drug cases, including cases involving  diabetes drugs Januvia®, Victoza®, Janumet®, and Byetta®; chemotherapy drug Taxotere®; gout medication Uloric®; MS medication Zinbryta®; and nausea medication Zofran®.


Consult a medical professional before stopping or changing any medication.

Motley Rice LLC, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through Motley Rice New Jersey LLC. Esther Berezofsky attorney responsible for New Jersey practice.